Acreage Announces Construction-Financing Loan
NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE:ACRG.A.U, ACRG.B.U), (OTCQX: ACRHF, ACRDF) today […]
Author Simplifies the Spelling of the English Language in New Book
VANCOUVER, Dec. 02, 2020 (GLOBE NEWSWIRE) — For hundreds of years now, there has been a desire to sort out […]
Osmotica Pharmaceuticals plc Announces Agreement to Settle Patent Litigation with Adamas
Adamas to acquire global rights to OSMOLEX ER® for $7.5 millionCompany to focus on maximizing commercial opportunity for Upneeq™BRIDGEWATER, N.J., […]
Cara Therapeutics Completes Full Enrollment in KARE Phase 2 Trial of Oral KORSUVA™ in Atopic Dermatitis Patients with Moderate-to-Severe Pruritus
– Topline data expected in first half of 2021 –STAMFORD, Conn., Dec. 02, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. […]
Seacoast Capital Exits Non-Control Growth Capital Investment in Cambium United
Boston, Massachusetts, Dec. 02, 2020 (GLOBE NEWSWIRE) — Seacoast Capital (“Seacoast”), a lower middle market non-control growth capital investor, announced […]
Inmar Intelligence Launches Exclusive Audiences Enabling Brands and Retailers to Target Health-Conscious Buyers Using Direct Purchase Data
Winston-Salem, NC, Dec. 02, 2020 (GLOBE NEWSWIRE) — Inmar Intelligence, a data-driven technology-enabled services company, announced the launch of Inmar […]
Amicus Therapeutics Appoints Michael A. Kelly to its Board of Directors
CRANBURY, N.J., Dec. 02, 2020 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced the election and appointment of Michael […]
GBT Initiates Early Access Program for Voxelotor in Patients with Sickle Cell Disease in Europe and Other Regions Outside the United States
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the […]
FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual Meeting
New data show safety and efficacy of roxadustat in treating anemia secondary to lower-risk myelodysplastic syndromes (MDS) regardless of ring […]
Adamas Announces Agreement to Amend Royalty-Backed Loan Agreement with HealthCare Royalty Partners
EMERYVILLE, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering […]